Search
 
1    2    3    4   
HomeTechnologyCompanyPipelinePartnersInvestorsContact Us
Press Releases
Jan 25, 2012
Generex Secures Commitments for $3.6M Capital Raise
Jan 17, 2012
Generex Subsidiary Antigen Express Featured on SNN Stock News Now; Highlights Advantages of Ii-Key Platform Technology for Cancer Immunotherapy
Jan 05, 2012
Generex Subsidiary Antigen Express Available for Partnering & Collaboration Meetings at the 2012 JPMorgan Healthcare Conference
All releases
Webcast Events and Media
  Second Annual "Cancer Immunotherapy: A Long-Awaited Reality" Conference at the New York Academy of Medicine
- Oct 06, 2011
  Rodman & Renshaw 13th Annual Healthcare Conference
- Sep 12, 2011
  Generex 2011 Annual Meeting
- Jun 08, 2011
  Generex Biotechnology Corporation CEO to Present Live, Online at RetailInvestorConferences.com
- May 05, 2011
  Generex Conference Call
- Mar 30, 2011
  Generex Press Conference Live Video Webcast from the NASDAQ MarketSite
- Mar 30, 2011
  Generex Live Video Webcast from the NASDAQ MarketSite
- Oct 21, 2010
  Generex Coporate Update
- Oct 12, 2010

Print Print     Email Email page

Investor Home


Investor Relations

For more information please contact:
Todd Falls
Tel: 1-800-391-6755
Fax: (647) 547-7104
Email: tfalls@generex.com


Exchange

OTC Bulletin Board
Listed Security

GNBT Common Stock
Transfer Agent

StockTrans, Inc.
44 West Lancaster Avenue
Ardmore, PA 19003
Phone 610-649-7300
Fax 610-649-7302

Corporate Counsel

Eckert Seamans Cherin & Mellott, LLC
1515 Market Street, 9th Floor
Philadelphia, PA 19102
Phone 215-851-8447
Fax 215-851-8383

Stock Quote
OTC BB: GNBT        0.16 + 0.00
27 Jan 2012    3:59 PM ET
Investor Tool Kit
PDF Corporate Fact Sheet
PDF Investor Presentation
HTML file Annual Report & Proxy

Privacy Policy Copyright © 2012